KT
Kitov Pharma
KTOV·NASDAQTel Aviv ILFounded 201010 employees
Micro CapbiotechPublicOncologyCNS
Platform: NT219 Onc
Market Cap
$0.01B
All Drugs
2
Clinical Trials
3
Failed / Terminated
0
FDA Approved
1
Stock Price & Catalysts (KTOV)
Loading KTOV stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Tixazasiran | KTO-5018 | Phase 1 | 1 | MET | NASHMelanoma | ||
| KTO-5045 | KTO-5045 | Approved | 2 | PCSK9 | RCCALS |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (3)